Mitral Splay Sign, Its Mechanism and Association With Severity of Regurgitation

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-01-01

Study Completion Date

2023-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To study echocardiography splay sign in mitral regurgitation and its association with mitral regurgitation severity and doppler band artifact ('seagull cry').

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mitral Regurgitation

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

echocardiography splay sign seagull cry

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

mitral splay sign

Patients with at least mild mitral regurgitation and splay sign on color doppler echocardiography

No interventions assigned to this group

no mitral splay sign

Patients with at least mild mitral regurgitation and no splay sign on color doppler echocardiography

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* any patient undergoing echocardiography for clinical indications

Exclusion Criteria

* poor quality of recorded echocardiography study
* inability to ascertain severity of mitral regurgitation

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Artemiy Okhotin

researcher in Digital Public Health Technologies

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Tarusa Hospital

Tarusa, Kaluga Oblast, Russia

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Russia

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Artemiy Okhotin, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TARUSA SPLAY STUDY

Identifier Type: -

Identifier Source: org_study_id